Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Liabilities from Discontinued Operations (2022 - 2024)

Mimedx's Liabilities from Discontinued Operations history spans 3 years, with the latest figure at 217000.0 for Q2 2024.

  • For Q2 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 217000.0; the TTM value through Jun 2024 reached 217000.0, changed N/A, while the annual FY2023 figure was 1352000.0, 8.59% down from the prior year.
  • Liabilities from Discontinued Operations for Q2 2024 was 217000.0 at Mimedx, down from 344000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 1479000.0 in Q4 2022 and bottomed at 217000.0 in Q2 2024.
  • The 3-year median for Liabilities from Discontinued Operations is 848000.0 (2023), against an average of 848000.0.
  • The largest YoY upside for Liabilities from Discontinued Operations was 8.59% in 2023 against a maximum downside of 8.59% in 2023.
  • A 3-year view of Liabilities from Discontinued Operations shows it stood at 1479000.0 in 2022, then decreased by 8.59% to 1352000.0 in 2023, then crashed by 83.95% to 217000.0 in 2024.
  • Per Business Quant, the three most recent readings for MDXG's Liabilities from Discontinued Operations are 217000.0 (Q2 2024), 344000.0 (Q1 2024), and 1352000.0 (Q4 2023).